Researchers like Dr. Catherine Wu, a professor of medicine at Harvard Medical School and the Dana-Farber Cancer Institute, are moving the field closer to attaining this goal. Wu and her colleagues ...

In A Nutshell Harvard researchers developed BrainIAC, a single AI model that can be adapted to analyze brain scans for ...

A groundbreaking phase 2 clinical trial has unveiled promising advancements in the treatment landscape for non-small cell lung cancer (NSCLC), ...

HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C.

T o make good decisions on any question the public needs to be well-informed, something not so easily accomplished in America’s schools. That is a key point made by Michael Kent, a recently retired ...

Inside a cancer research laboratory on the campus of Harvard Medical School, two dozen small jars with pink plastic lids sat on a metal counter. Inside these humble-looking jars is the core of Joan ...

The National Cancer Plan outlines a clear approach to improving cancer care, with the aim that by 2035, three in four people diagnosed with cancer will survive for at least five years.

A hallmark of Parkinson's disease is the buildup of Lewy bodies—misfolded clumps of the protein known as alpha-synuclein.

Among them was David Liu, a biochemist at the Broad Institute and Harvard University in Cambridge, Massachusetts. Liu isn’t a ...

Scientists are testing an entirely new way to fight heart disease: whether gene editing might offer a one-time fix for high ...

With a shared purpose, we can realize the true promise of CRISPR and improve healthcare, providing hope to more patients with ...